Barriers to Accessing Healthcare Services for People with Parkinson's Disease: A Scoping Review

Overview

Journal J Parkinsons Dis

Publisher Sage Publications

Specialty Neurology

Date 2021 Jul 26

PMID 34308913

Citations 19

Authors

Muhammed Shahriar Zaman

Setareh Ghahari

Mary Ann McColl

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease is a complex condition that affects many different aspects of a person's health. Because of its complexity, people with Parkinson's disease require access to a variety of healthcare services. The aim of the present study was to identify the barriers to access healthcare services for people with Parkinson's disease. We conducted a scoping review according to guidelines posed by Arksey & O'Malley (2005). A search of MEDLINE, Embase, CINHAL, and PsycINFO databases was conducted, and 38 articles were selected based on the inclusion criteria. The review findings identified person-level and system-level barriers. The person-level barriers included skills required to seek healthcare services, ability to engage in healthcare and cost for services. The system-level barriers included the availability of appropriate healthcare resources. Based on the existing barriers elucidated in the scope review, we have discussed potential areas in healthcare that require improvement for people with Parkinson's disease to manage their healthcare needs more equitably.

Citing Articles

Race and ethnicity matter! Moving Parkinson's risk research towards diversity and inclusiveness.

Siddiqi S, Ortiz Z, Simard S, Li J, Lawrence K, Redmond M NPJ Parkinsons Dis. 2025; 11(1):45.

PMID: 40050644 PMC: 11885646. DOI: 10.1038/s41531-025-00891-7.

'I'm Not Sure Who to Refer You to': Experiences of Clinicians Accessing Allied Health for Their Patients With Parkinson's Disease.

Wong C, Dennis S, Allen N, Paul S J Eval Clin Pract. 2025; 31(2):e70044.

PMID: 40040291 PMC: 11880745. DOI: 10.1111/jep.70044.

Accelerated symptom improvement in Parkinson's disease via remote internet-based optimization of deep brain stimulation therapy: a randomized controlled multicenter trial.

Gharabaghi A, Groppa S, Navas-Garcia M, Schnitzler A, Munoz-Delgado L, Marshall V Commun Med (Lond). 2025; 5(1):31.

PMID: 39890864 PMC: 11785990. DOI: 10.1038/s43856-025-00744-7.

Effectiveness of a home-based computerized cognitive training in Parkinson's disease: a pilot randomized cross-over study.

Tagliente S, Minafra B, Aresta S, Santacesaria P, Buccoliero A, Palmirotta C Front Psychol. 2025; 15():1531688.

PMID: 39850970 PMC: 11754226. DOI: 10.3389/fpsyg.2024.1531688.

Wearable devices may aid the recognition of fluctuation-related pain in Parkinson's disease-An exploratory, cross-sectional analysis of two prospective observational studies.

Rukavina K, Staunton J, Zinzalias P, Krbot Skoric M, Wu K, Bannister K PLoS One. 2025; 20(1):e0316563.

PMID: 39808664 PMC: 11731749. DOI: 10.1371/journal.pone.0316563.

References

Peto V, Fitzpatrick R, Jenkinson C . Self-reported health status and access to health services in a community sample with Parkinson's disease. Disabil Rehabil. 1997; 19(3):97-103. DOI: 10.3109/09638289709166833. View

Bainbridge J, Ruscin J . Challenges of treatment adherence in older patients with Parkinson's disease. Drugs Aging. 2009; 26(2):145-55. DOI: 10.2165/0002512-200926020-00006. View

Schuller K, Vaughan B, Wright I . Models of Care Delivery for Patients With Parkinson Disease Living in Rural Areas. Fam Community Health. 2017; 40(4):324-330. DOI: 10.1097/FCH.0000000000000159. View

van der Eijk M, Nijhuis F, Faber M, Bloem B . Moving from physician-centered care towards patient-centered care for Parkinson's disease patients. Parkinsonism Relat Disord. 2013; 19(11):923-7. DOI: 10.1016/j.parkreldis.2013.04.022. View

Worth P . A perspective on the current issues in the diagnosis of Parkinson's disease. Br J Hosp Med (Lond). 2007; 68(5):S6, S8-11, S14-5. DOI: 10.12968/hmed.2007.68.5.23348. View

Prasad S, Holla V, Neeraja K, Surisetti B, Kamble N, Yadav R . Impact of Prolonged Lockdown due to COVID-19 in Patients with Parkinson's Disease. Neurol India. 2020; 68(4):792-795. DOI: 10.4103/0028-3886.293472. View

Khalil H, Nazzal M, Al-Sheyab N . Parkinson's disease in Jordan: Barriers and motivators to exercise. Physiother Theory Pract. 2016; 32(7):509-19. DOI: 10.1080/09593985.2016.1219433. View

Lennaerts H, Steppe M, Munneke M, Meinders M, van der Steen J, van den Brand M . Palliative care for persons with Parkinson's disease: a qualitative study on the experiences of health care professionals. BMC Palliat Care. 2019; 18(1):53. PMC: 6617627. DOI: 10.1186/s12904-019-0441-6. View

Shin J, Habermann B . Initiation of medications for Parkinson's disease: a qualitative description. J Clin Nurs. 2015; 25(1-2):127-33. DOI: 10.1111/jocn.13009. View

10.

Dahodwala N, Shah K, He Y, Wu S, Schmidt P, Cubillos F . Sex disparities in access to caregiving in Parkinson disease. Neurology. 2017; 90(1):e48-e54. PMC: 10681055. DOI: 10.1212/WNL.0000000000004764. View

11.

DeWalt D, Berkman N, Sheridan S, Lohr K, Pignone M . Literacy and health outcomes: a systematic review of the literature. J Gen Intern Med. 2004; 19(12):1228-39. PMC: 1492599. DOI: 10.1111/j.1525-1497.2004.40153.x. View

12.

Dahodwala N, Xie M, Noll E, Siderowf A, Mandell D . Treatment disparities in Parkinson's disease. Ann Neurol. 2009; 66(2):142-5. PMC: 2856321. DOI: 10.1002/ana.21774. View

13.

Daley D, Myint P, Gray R, Deane K . Systematic review on factors associated with medication non-adherence in Parkinson's disease. Parkinsonism Relat Disord. 2012; 18(10):1053-61. DOI: 10.1016/j.parkreldis.2012.09.004. View

14.

Mestre T, Teodoro T, Reginold W, Graf J, Kasten M, Sale J . Reluctance to start medication for Parkinson's disease: a mutual misunderstanding by patients and physicians. Parkinsonism Relat Disord. 2014; 20(6):608-12. DOI: 10.1016/j.parkreldis.2014.03.001. View

15.

Pringsheim T, Jette N, Frolkis A, Steeves T . The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014; 29(13):1583-90. DOI: 10.1002/mds.25945. View

16.

Richfield E, Jones E, Alty J . Palliative care for Parkinson's disease: a summary of the evidence and future directions. Palliat Med. 2013; 27(9):805-10. DOI: 10.1177/0269216313495287. View

17.

Lubomski M, Rushworth R, Lee W, Bertram K, Williams D . A cross-sectional study of clinical management, and provision of health services and their utilisation, by patients with Parkinson's disease in urban and regional Victoria. J Clin Neurosci. 2012; 20(1):102-6. DOI: 10.1016/j.jocn.2012.05.015. View

18.

Dahodwala N, Siderowf A, Xie M, Noll E, Stern M, Mandell D . Racial differences in the diagnosis of Parkinson's disease. Mov Disord. 2009; 24(8):1200-5. PMC: 2858583. DOI: 10.1002/mds.22557. View

19.

Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T . The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2016; 46(4):292-300. DOI: 10.1159/000445751. View

20.

Valldeoriola F, Coronell C, Pont C, Buongiorno M, Camara A, Gaig C . Socio-demographic and clinical factors influencing the adherence to treatment in Parkinson's disease: the ADHESON study. Eur J Neurol. 2011; 18(7):980-7. DOI: 10.1111/j.1468-1331.2010.03320.x. View